Cargando…
Prostate cancer stem cells
Despite the discovery over 60 years ago by Huggins and Hodges 1 that prostate cancers respond to androgen deprivation therapy, hormone-refractory prostate cancer remains a major clinical challenge. There is now mounting evidence that solid tumours originate from undifferentiated stem cell-like cells...
Autores principales: | Lang, SH, Frame, FM, Collins, AT |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673349/ https://www.ncbi.nlm.nih.gov/pubmed/19040209 http://dx.doi.org/10.1002/path.2478 |
Ejemplares similares
-
The regulatory pathways leading to stem-like cells underlie prostate cancer progression
por: Lin, Chun-Jung, et al.
Publicado: (2019) -
The role of mRNA splicing in prostate cancer
por: Lapuk, Anna V, et al.
Publicado: (2014) -
Circulating tumor cells and their role in prostate cancer
por: Maas, Moritz, et al.
Publicado: (2019) -
Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer
por: Zhu, Yini, et al.
Publicado: (2022) -
Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms
por: Huang, Yu-Hua, et al.
Publicado: (2019)